← Back to Search

Pharmacist-Led Cardiovascular Risk Service for Reducing Heart Disease Risk (CVRSLive Trial)

N/A

Waitlist Available

Led By Korey Kennelty, PharmD

Research Sponsored by Korey Kennelty

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Currently has one of the following diseases: Diabetes with HA1c 9.0% or greater and/or Hypertension (uncomplicated) with systolic blood pressure 150 mm Hg or greater

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 36 months following the start of recruitment

Awards & highlights

CVRSLive Trial Summary

This trial will study how effective a remote, pharmacist-led cardiovascular risk service is in 12 hospitals with diverse patients.

Who is the study for?

This trial is for English or Spanish speakers who have visited the clinic in the past year and are currently managing diabetes with an HA1c of 9.0%+ or high blood pressure with a systolic reading of 150 mm Hg+. It's not open to those unable to consent, living in nursing homes, without a phone, diagnosed with short-term cancer prognosis, pregnant women, dementia patients, or planning to leave the clinic soon.Check my eligibility

What is being tested?

The study is testing a remote cardiovascular risk service led by pharmacists across diverse hospitals. The aim is to see how well this service can be implemented in different settings and its effectiveness for patients with high blood pressure and diabetes.See study design

What are the potential side effects?

Since this intervention involves a non-medical service focusing on cardiovascular risk management rather than medication or procedures, traditional side effects are not applicable. However, there may be indirect effects related to changes in health management.

CVRSLive Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have diabetes with an HA1c of 9.0% or higher, or I have hypertension with a systolic blood pressure of 150 mm Hg or higher.

CVRSLive Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 36 months following the start of recruitment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~36 months following the start of recruitment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months following the start of recruitment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Effect of physician/pharmacist collaboration on implementation fidelity

Factors influencing intervention implementation fidelity

Secondary outcome measures

Adherence to guidelines for primary and secondary prevention of cardiovascular disease

Development of payment contracts

Reach and adoption of intervention

CVRSLive Trial Design

2Treatment groups

Experimental Treatment

Group I: CVRS Early InterventionExperimental Treatment1 Intervention

Patients participating in intervention offices will receive the pharmacist-led CVRS intervention for 12 months.

Group II: CVRS Delayed InterventionExperimental Treatment1 Intervention

Patients participating in control site offices will not have any contact with the CVRS pharmacist for the first 12 months of their participation in the study. They will receive the study intervention during months 13-24.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CVRS Intervention

2015

N/A

~410

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Korey KenneltyLead Sponsor

3 Previous Clinical Trials

724 Total Patients Enrolled

Korey Kennelty, PharmDPrincipal InvestigatorUniversity of Iowa

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for applicants in this clinical trial?

"Derived from the information on clinicaltrials.gov, this trial is not presently enlisting participants. First posted on September 27th 2018 and last updated two years ago, it is one of 1873 trials currently available but not actively seeking patients at this moment in time."

Answered by AI

In what geographical locations is this clinical research being conducted?

"14 distinct clinical sites are currently supporting this medical trial, including locations in Pocatello, Detroit and Waterloo. To minimise the travel burden of participation, participants should select their nearest site."

Answered by AI

What are the fundamental goals of this medical experiment?

"The principal aim of this research, assessed over the course of a year following intervention initiation at each site is to appraise the influence physician/pharmacist collaboration has on implementation fidelity. Further objectives include ascertaining reach and adoption of the treatment programme, measuring adherence to cardiovascular disease prevention guidelines between both arms, and establishing payment contracts with CVRS."

Answered by AI